 |
Principal
Investigator: Richard
Rosen, MD
Enrollment
Status:
Open
Objective:
The primary objectives of the MacTel Research Project are to enroll subjects with macular telangiectasia of the group 2 type, to document structural and functional changes, and to follow subjects over a period of up to five (5) years. Data will be analyzed to identify potential risk factors and related outcomes.
Eligibility:
Contact Principal
Investigator/Coordinator
Contact
Information:
- Principal
Investigator: Richard Rosen, MD at (212) 979-4284
- Anita Ou, CRC (212) 979-4672 and
Katy Tai, CR Manager (212) 979-4251
|